Propranolol-induced seizures in mice: the role of noradrenaline

被引:7
作者
Amabeoku, GJ
Syce, JA
机构
[1] Department of Pharmacology, School of Pharmacy, University of Western Cape, Bellville 7535
关键词
propranolol; seizures; noradrenergic mechanism; mice;
D O I
10.1007/s000180050083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of some noradrenergic agents, phenobarbitone, diazepam and phenytoin on seizures produced by propranolol were investigated in mice. Isoprenaline and DL-threo-3,4-dihydroxyphenylserine (DOPS) effectively antagonized the seizures elicited by propranolol. Pargyline and imipramine significantly attenuated propranolol-induced seizures and also significantly potentiated the protecting effect of DOPS against the seizures. alpha-Methyl-p-tyrosine disulfiram and reserpine significantly potentiated propranolol-elicited seizures. However, DOPS significantly antagonized the seizure-potentiating effects of alpha-methyl-p-tyrosine, disulfiram and reserpine. Phenylephrine, clonidine, prazosin, idazoxan, phenobarbitone, diazepam and phenytoin did not significantly alter propranolol-induced seizures. These results suggest that propranolol-induced seizures in mice may involve a noradrenergic mechanism mediated via central beta-adrenoceptors.
引用
收藏
页码:646 / 651
页数:6
相关论文
共 28 条
[1]   THE INVOLVEMENT OF NORADRENALINE, 5-HYDROXYTRYPTAMINE AND ACETYLCHOLINE IN IMIPRAMINE-INDUCED SEIZURES IN MICE [J].
AMABEOKU, GJ .
EXPERIENTIA, 1993, 49 (10) :859-864
[2]   THE FORMATION OF NORADRENALINE FROM DIHYDROXYPHENYLSERINE [J].
BLASCHKO, H ;
BURN, JH ;
LANGEMANN, H .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1950, 5 (03) :431-437
[3]   SEIZURES AND INTRA-VENTRICULAR CONDUCTION DEFECT IN PROPRANOLOL POISONING - REPORT OF 2 CASES [J].
BUIUMSOHN, A ;
EISENBERG, ES ;
JACOB, H ;
ROSEN, N ;
BOCK, J ;
FRISHMAN, WH .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :860-862
[4]  
CHERMAT R, 1981, N-S ARCH PHARMACOL, V318, P94
[5]  
DADKAR VN, 1979, INDIAN J MED RES, V70, P492
[6]  
DESCHAEPDRYVER AF, 1962, ARCH INT PHARMACOD T, V140, P358
[7]  
FLETCHER A, 1984, British Journal of Pharmacology, V81, p39P
[8]  
FORSTER RW, 1996, BASIC PHARM, P76
[9]  
FORSTER RW, 1996, BASIC PHARM, P232
[10]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .8. SELF-POISONING WITH BETA-ADRENOCEPTOR BLOCKING-AGENTS - RECOGNITION AND MANAGEMENT [J].
FRISHMAN, W ;
JACOB, H ;
EISENBERG, E ;
RIBNER, H .
AMERICAN HEART JOURNAL, 1979, 98 (06) :798-811